Intelligent Bio Solutions Inc. (INBS) income statement
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.54−0.02 (-1.28%)
Close on Nov 18, 2026Market cap $4.66MP/E –Yield –
Intelligent Bio Solutions Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 48.6%
- Operating margin
- -299.1%
- Net margin
- -294.9%
- Return on equity, FY2026
- -292.3%
Financial strength
- Current ratio
- 1.44
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 81.0%
Valuation
- P/E ratio
- –
- Price to sales
- 1.11
- Price to book
- 0.85
- Dividend yield
- –
See a number that looks wrong?